However, as Hanahan and Weinberg [2] point out, alterations of TGF-β signalling in cancer are not only limited to its loss of function but also to the perversion of its functions; that is, tumour cells can exploit TGF-β functions to their own advantage. Here, TGFB1 is linked to cancer.